1. Home
  2. CTM vs GOSS Comparison

CTM vs GOSS Comparison

Compare CTM & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTM

Castellum Inc.

N/A

Current Price

$0.44

Market Cap

63.1M

Sector

Technology

ML Signal

N/A

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

N/A

Current Price

$11.27

Market Cap

70.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTM
GOSS
Founded
2019
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.1M
70.8M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
CTM
GOSS
Price
$0.44
$11.27
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $91.40
AVG Volume (30 Days)
★ 536.1K
164.9K
Earning Date
11-05-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 83.33
N/A
EPS
★ N/A
N/A
Revenue
★ $52,866,001.00
$48,471,000.00
Revenue This Year
$4.94
N/A
Revenue Next Year
$8.17
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 18.10
N/A
52 Week Low
$0.34
$0.11
52 Week High
$1.24
$12.52

Technical Indicators

Market Signals
Indicator
CTM
GOSS
Relative Strength Index (RSI) 39.52 60.20
Support Level $0.34 $0.18
Resistance Level $0.66 $12.49
Average True Range (ATR) 0.04 1.09
MACD -0.00 0.09
Stochastic Oscillator 50.23 71.04

Price Performance

Historical Comparison
CTM
GOSS

About CTM Castellum Inc.

Castellum Inc is focused on building a successful technology services, solutions, and products company in the areas of cybersecurity, IT, electronic warfare, information warfare, system modernization, and information operations with businesses in the defense, federal, civilian, and commercial markets. Services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model-based systems engineering. The company maintains one operating and reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: